|
|
 |
|
INDUSTRY NEWS
Cedars-Sinai to Supply Stem Cells to Scientists Developing Treatments for Huntington's Disease
As part of the $3.7 million grant from the National Institutes of Health, the Cedars-Sinai Regenerative Medicine Institute, directed by Clive Svendsen, Ph.D., will supply scientists at five leading laboratories, including Cedars-Sinai, with all the adult stem cells used in the study.
Effort to Regenerate Damaged Spinal Cords Receives Federal Stimulus
Fueled by the National Institutes of Health Grand Opportunity grant of $2.4 million, a multi-institutional team of researchers associated with the University of Florida McKnight Brain Institute's Regeneration Project has begun creating genomic tools necessary to compare the extraordinary regenerative capacity of the Mexican axolotl salamander with established mouse models of human disease and injury.
Otago Researchers Gain Neurological Foundation Grants
University of Otago researchers have gained significant funding for brain health-related studies in the Neurological Foundation of New Zealand's latest funding round.
University of Florida to Lead National Effort to Help Patients with Rare Brain Disease
University of Florida neurologists are trying to aid patients with ataxia with the help of a $1 million Challenge grant from the National Institute of Neurological Disorders and Stroke to establish a nationwide network of physician-scientists with expertise in clinical ataxia research.
Regeneron Plans $40 Million Expansion, Adding 400 Jobs
Regeneron Pharmaceuticals Inc. is investing $40 million in an expansion that will create up to 100 jobs in East Greenbush and another 300 jobs at its Westchester County campus.
Stem Cell Therapeutics Corp. Adds Another U.S. Patent to Its Intellectual Property Portfolio
Stem Cell Therapeutics Corp. announced recently that it has been granted U.S. Patent No. 7,629,169 entitled "Methods for the Production of Platelet-Derived Growth Factor (PDGF)-Responsive Neural Precursor Cells". The claims cover methods of producing and self-renewing PDGF-responsive precursor cells in culture using PDGF and FGF-2.
|
|
|
POLICY NEWS
National Institutes of Health Approves 27 More Stem Cell Lines
National Institutes of Health chief Francis Collins approved another 27 human embryonic stem cell lines for federal research funding recently, but limited support to diabetes-related pancreatic cell experiments. [National Institutes of Health, United States]
CIRM Provides $11 Million Boost in Funding to Train Stem Cell Scientists
Two critical programs funded by the California Institute for Regenerative Medicine (CIRM), the state stem cell agency, got an $11 million increase recently when the agency's 29-member Governing Board voted to approve funding for two additional grants in the Training II program and five additional grants in the Bridges program. [California Institute for Regenerative Medicine, United States]
State Stem Cell Funding Possibly In Jeopardy
State money has helped Connecticut carve a niche in stem cell research, luring top scientists to the state and funding more than 200 researchers at the University of Connecticut, Yale and Wesleyan as they pursue treatments for cancer, Parkinson's and other diseases using promising new methods. [University of Connecticut, Yale and Wesleyan, United States]
FOOD AND DRUG ADMINISTRATION (United States)
Delays in Grant Application Submission due to Winter Storm December 2009 (NOT-OD-10-028)
|
|
|
EVENTS
The Biology and Pathology of Tau and Its Role in Tauopathies
January 7-8, 2010
Cambridge, United Kingdom
Keystone Symposia: Alzheimer's Disease Beyond Abeta (A4)
January 10-15, 2010
Copper Mountain, United States
CHI's Molecular Medicine Tri-Conference 2010
February 3-5, 2010
San Francisco, United States
Keystone Symposia: Stem Cell Differentiation and Dedifferentiation (B4)
February 15-20, 2010
Keystone, United States
2010 Canadian Neuroscience Meeting
May 15-18, 2010
Ottawa, Canada
ISSCR 8th Annual Meeting
June 16-19, 2010
San Francisco, United States
JOB OPPORTUNITIES
Business Development Europe - Cell Therapy Products (PALL Corporation)
Research & Development Scientist - Mesenchymal Cell Biology (STEMCELL Technologies)
Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization's career opportunities with Cell Therapy News.
Visit here to post your career opportunities.
|
|
|
This email was sent by: Connexon Creative
201-375 W. 5th Avenue Vancouver, British Columbia V5Y1J6 Canada |
|
|